Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ACM NASDAQ:NEO NYSE:PRG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACMAECOM$111.04-1.5%$112.35$84.75▼$118.56$14.92B0.99811,481 shs1.07 million shsNEONeoGenomics$5.16+6.6%$6.99$4.72▼$19.11$625.22M1.552.52 million shs4.53 million shsPRGAaron's$30.49-4.2%$29.68$23.50▼$50.28$1.28B1.75450,447 shs517,905 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACMAECOM-1.47%-3.71%-3.05%+8.42%+22.59%NEONeoGenomics+6.61%-17.97%-30.27%-32.99%-70.90%PRGAaron's-4.16%-6.65%-0.16%+12.59%-32.35%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACMAECOM4.421 of 5 stars2.55.01.71.74.01.71.9NEONeoGenomics4.0082 of 5 stars4.25.00.00.01.63.31.3PRGAaron's4.7106 of 5 stars3.45.02.50.02.93.33.1Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACMAECOM 3.00Buy$125.8613.34% UpsideNEONeoGenomics 2.33Hold$12.88149.52% UpsidePRGAaron's 2.71Moderate Buy$41.0034.47% UpsideCurrent Analyst Ratings BreakdownLatest NEO, TCY, ACM, and PRG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/30/2025NEONeoGenomicsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$10.00 ➝ $8.007/30/2025NEONeoGenomicsBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Neutral7/29/2025NEONeoGenomicsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.50 ➝ $8.007/29/2025NEONeoGenomicsWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform7/28/2025ACMAECOMCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$122.00 ➝ $137.007/16/2025ACMAECOMKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$120.00 ➝ $129.007/14/2025PRGAaron'sBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeNeutral ➝ Sell$24.005/15/2025NEONeoGenomicsGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral5/7/2025ACMAECOMRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$123.00 ➝ $126.005/7/2025ACMAECOMCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$116.00 ➝ $122.005/6/2025NEONeoGenomicsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$18.00 ➝ $12.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACMAECOM$16.11B0.91$5.84 per share19.00$17.68 per share6.28NEONeoGenomics$660.57M1.01$0.47 per share11.03$6.61 per share0.78PRGAaron's$2.46B0.50$42.35 per share0.72$16.57 per share1.84Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACMAECOM$402.27M$4.5924.1919.651.823.85%27.67%5.65%8/4/2025 (Estimated)NEONeoGenomics-$78.73M-$0.61N/A57.33N/A-15.10%-2.72%-1.54%N/APRGAaron's$197.25M$5.066.037.38N/A8.53%22.54%9.98%N/ALatest NEO, TCY, ACM, and PRG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2025Q3 2025ACMAECOM$1.25N/AN/AN/A$4.33 billionN/A7/23/2025Q2 2025PRGAaron's$0.79$1.02+$0.23$0.95$586.25 million$604.66 million5/5/2025Q2 2025ACMAECOM$1.15$1.25+$0.10$1.08$4.18 billion$3.77 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACMAECOM$1.040.94%N/A22.66%3 YearsNEONeoGenomicsN/AN/AN/AN/AN/APRGAaron's$0.521.71%N/A10.28%2 YearsLatest NEO, TCY, ACM, and PRG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/4/2025ACMAECOMquarterly$0.260.94%7/2/20257/2/20257/18/20255/8/2025PRGAaron'squarterly$0.131.8%5/20/20255/20/20256/3/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACMAECOM1.001.151.15NEONeoGenomics0.403.921.95PRGAaron's0.895.712.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACMAECOM85.41%NEONeoGenomics98.50%PRGAaron's97.92%Insider OwnershipCompanyInsider OwnershipACMAECOM0.41%NEONeoGenomics2.40%PRGAaron's3.21%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACMAECOM51,000132.30 million131.76 millionOptionableNEONeoGenomics2,200129.18 million126.08 millionOptionablePRGAaron's1,40340.35 million39.06 millionNot OptionableNEO, TCY, ACM, and PRG HeadlinesRecent News About These CompaniesVulcan Value Partners LLC Acquires 311,917 Shares of Aaron's Holdings Company, Inc. (NYSE:PRG)August 1 at 4:37 AM | marketbeat.comDespite Fast-paced Momentum, PROG Holdings (PRG) Is Still a Bargain StockJuly 31 at 9:51 AM | zacks.comGSA Capital Partners LLP Takes Position in Aaron's Holdings Company, Inc. (NYSE:PRG)July 29, 2025 | marketbeat.comY Intercept Hong Kong Ltd Makes New $483,000 Investment in Aaron's Holdings Company, Inc. (NYSE:PRG)July 28, 2025 | marketbeat.comAaron's (NYSE:PRG) Cut to Hold at Wall Street ZenJuly 26, 2025 | marketbeat.comIs Prog Holdings (PRG) Stock Undervalued Right Now?July 25, 2025 | zacks.comAllianz Asset Management GmbH Acquires 127,384 Shares of Aaron's Holdings Company, Inc. (NYSE:PRG)July 25, 2025 | marketbeat.comAaron's (NYSE:PRG) Issues FY 2025 Earnings GuidanceJuly 24, 2025 | marketbeat.comAaron's (NYSE:PRG) Issues Q3 2025 Earnings GuidanceJuly 24, 2025 | marketbeat.comAaron's (NYSE:PRG) Issues Quarterly Earnings ResultsJuly 24, 2025 | marketbeat.comAaron's (NYSE:PRG) Shares Gap Up After Earnings BeatJuly 24, 2025 | americanbankingnews.comPROG Holdings, Inc. (PRG) Q2 2025 Earnings Call TranscriptJuly 23, 2025 | seekingalpha.comAaron's (NYSE:PRG) Shares Gap Up After Strong EarningsJuly 23, 2025 | marketbeat.comPROG Holdings (PRG) Q2 Earnings and Revenues Top EstimatesJuly 23, 2025 | zacks.comPROG Holdings Reports Second Quarter 2025 ResultsJuly 23, 2025 | businesswire.comBank of New York Mellon Corp Cuts Stake in Aaron's Holdings Company, Inc. (NYSE:PRG)July 22, 2025 | marketbeat.com42,000 Shares in Aaron's Holdings Company, Inc. (NYSE:PRG) Purchased by Hussman Strategic Advisors Inc.July 19, 2025 | marketbeat.comAaron's (PRG) to Release Quarterly Earnings on WednesdayJuly 16, 2025 | marketbeat.comAaron's (NYSE:PRG) Stock Price Down 3.8% - Here's WhyJuly 14, 2025 | marketbeat.comAaron's (NYSE:PRG) Cut to "Sell" at BTIG ResearchJuly 14, 2025 | marketbeat.comTeacher Retirement System of Texas Cuts Stake in Aaron's Holdings Company, Inc. (NYSE:PRG)July 14, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNEO, TCY, ACM, and PRG Company DescriptionsAECOM NYSE:ACM$111.04 -1.70 (-1.51%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$111.06 +0.02 (+0.01%) As of 08/1/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AECOM, together with its subsidiaries, provides professional infrastructure consulting services worldwide. It operates in three segments: Americas, International, and AECOM Capital. The company offers planning, consulting, architectural and engineering design, construction and program management, and investment and development services to public and private clients. It is also involved in the investment and development of real estate projects. In addition, the company provides construction services, including building construction and energy, and infrastructure and industrial construction. It serves transportation, water, government, facilities, environmental, and energy sectors. The company was formerly known as AECOM Technology Corporation and changed its name to AECOM in January 2015. AECOM was incorporated in 1980 and is headquartered in Dallas, Texas.NeoGenomics NASDAQ:NEO$5.16 +0.32 (+6.61%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$5.16 0.00 (-0.10%) As of 08/1/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.Aaron's NYSE:PRG$30.49 -1.35 (-4.24%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$30.76 +0.27 (+0.87%) As of 08/1/2025 05:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PROG Holdings, Inc. (NYSE:PRG) is a financial technology holding company based in Salt Lake City, Utah with three business segments: Progressive Leasing, which offers lease-to-own transactions primarily to credit-challenged consumers through e-commerce and point-of-sale retail partners, via online, mobile, and in-store solutions; Vive Financial, which provides consumers who may not qualify for traditional prime lending with a variety of second-look, revolving credit products through private label and branded credit cards; and Four Technologies, which provides consumers of all credit backgrounds Buy Now, Pay Later (BNPL) options through four interest-free installments via its platform, Four. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
